In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight at 72 weeks (Jastreboff et al., NEJM , 2022), compared to roughly 15 percent with semaglutide 2.4 mg in the STEP 1 trial (Wilding et al., NEJM , 2021)
Through the online portal, patients can make follow-up appointments, have their prescriptions adjusted, and more all virtually
Many patients who chose to file a lawsuit against a semaglutide manufacturer allegedly suffered gastroparesis as a result of using a prescribed drug
Hers appeals to women seeking integrated health management alongside weight-loss medication
Every year, the World Anti-Doping Agency (WADA) publishes an updated Prohibited List